Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes

CONTEXT: In healthy individuals, glucose-dependent insulinotropic polypeptide (GIP) enhances insulin secretion and reduces bone resorption by up to 25% estimated by absolute placebo-corrected changes in carboxy-terminal type 1 collagen crosslinks (CTX) during GIP and glucose administration. In patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Mikkel B, Lund, Asger B, Jørgensen, Niklas R, Holst, Jens J, Vilsbøll, Tina, Knop, Filip K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458112/
https://www.ncbi.nlm.nih.gov/pubmed/32904711
http://dx.doi.org/10.1210/jendso/bvaa097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458112/
https://www.ncbi.nlm.nih.gov/pubmed/32904711
http://dx.doi.org/10.1210/jendso/bvaa097

Ejemplares similares